ArticleNature communications2026
Distinct genomic trajectory among invasive Salmonella Typhimurium ST313 infections.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- ZoonoticEmerging microbes & infections · 2026Article
- Salmonella species in foods of animal origin, their virulence potential and antibiotic susceptibility in India: implications for public health.Veterinary research communications · 2026Article
- Article
- One Health genomics reveals niche-specific lineage replacement inNational science review · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Invasive non-typhoidal Salmonella (iNTS) disease, primarily manifesting as bloodstream infections and dominated by Salmonella Typhimurium sequence type 313 (ST313), represents a major global health challenge, particularly in sub-Saharan Africa. However, the transmission landscape and evolutionary driver of ST313 remain incompletely understood. Here, we compile the global dataset to date, comprising 11,361 human-derived iNTS genomes and 3115 ST313 genomes from diverse sources, enabling identification of a highly antimicrobial-resistant sublineage 2.4 and an emerging lineage 4. Phylogenomic analyses reveal patterns consistent with intercontinental dissemination of ST313, which may be associated with modernized human biomass movement. Sublineage 2.4, an antimicrobial-resistant offshoot that displaced lineage 1, harbors extended-spectrum β-lactamase genes, including bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.